Skip to main content
OpenTrials

Clinical trial condition

Leukopenia

Explore clinical trials studying Leukopenia. Study availability and eligibility vary by location and protocol.

355 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Leukopenia trial results

Completed

Gene Therapy for WAS

NCT01347346

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hôpital Necker-Enfants Malades Paris, France
View Trial Details
Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

NCT03511820

Conditions
Agranulocytosis, Cytopenia, Febrile Neutropenia, +6 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Keelung Chang Gung Memorial Hospital Keelung, Taiwan
View Trial Details
Completed

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

NCT00911170

Conditions
Agranulocytosis, Body Temperature Changes, Cancer, +28 more
Locations
  • Research Site Muscle Shoals, Alabama, United States
  • Research Site Jonesboro, Arkansas, United States
  • Research Site Anaheim, California, United States
  • Research Site Beverly Hills, California, United States
View all 154 locations
View Trial Details
Completed

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

NCT00771810

Conditions
Adnexal Diseases, Agranulocytosis, Anemia, +25 more
Locations
  • University of Southern Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • USC - LAC Medical Center Los Angeles, California, United States
  • University of California - Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Completed

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

NCT01516736

Conditions
Agranulocytosis, Breast Cancer, Breast Diseases, +12 more
Locations
  • Sandoz Investigational Site Hot Springs, Arkansas, United States
  • Sandoz Investigational Site Jonesboro, Arkansas, United States
  • Sandoz Investigational Site Corona, California, United States
  • Sandoz Investigational Site Wichita, Kansas, United States
View all 53 locations
View Trial Details
Completed

Interleukin-2 Treatment for Wiskott-Aldrich Syndrome

NCT00774358

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • The Texas Children's Hospital Houston, Texas, United States
View Trial Details

Related conditions